Diagnostic Approaches for Helicobacter pylori Infection

Non-Invasive Diagnostic Tests

The American College of Gastroenterology recommends the urea breath test (UBT) and stool antigen test as the primary non-invasive diagnostic tests for Helicobacter pylori infection, with UBT demonstrating sensitivity of 94-97% and specificity of 95%, and stool antigen test showing sensitivity and specificity of approximately 93% 1, 2, 3
UBT is considered the most accurate non-invasive test, detecting active H. pylori infection by measuring urease activity, and is part of the recommended "test and treat" strategy for young dyspeptic patients without alarm symptoms, with patients required to fast for at least 6 hours before the test for optimal accuracy 2, 3
The stool antigen test directly detects H. pylori bacterial antigens in stool specimens, is comparable to UBT in accuracy, and is an excellent alternative for both initial diagnosis and post-treatment confirmation, with a laboratory-based validated monoclonal stool antigen test specifically recommended 1, 3

Histological examination is considered a gold standard among invasive tests, requiring at least two biopsy samples from the antrum and body for improved sensitivity, with several staining methods available, including modified Giemsa and immunohistochemistry, which is the established gold standard for histology with high sensitivity and specificity 4
Rapid urease test (RUT) is based on the activity of H. pylori urease enzyme, has pre-treatment sensitivity ranges from 80-95% with specificity of 95-100%, and requires approximately 10^4 organisms for a positive result 4
Culture provides definitive proof of infection, allows for antimicrobial susceptibility testing, but is technically demanding with variable sensitivity between laboratories, and is particularly valuable after treatment failure when antimicrobial resistance is suspected 3, 4

False negative results can occur with all tests if patients have recently taken proton pump inhibitors (should be discontinued at least 2 weeks before testing), antibiotics (should be discontinued at least 4 weeks before testing), or bismuth compounds 1, 3
Serological tests are not recommended for confirming active infection because they cannot distinguish between active infection and past exposure, antibody levels persist in blood long after eradication, and overall accuracy of commercial ELISA serology tests averages only 78% 3, 5
For confirmation of eradication, testing should be performed no earlier than 4 weeks after completion of treatment, using UBT or stool antigen test, and never using serology to confirm eradication 3

The European Society of Gastrointestinal Endoscopy recommends avoiding rapid in-office immunochromatographic stool tests for H. pylori diagnosis due to their lower accuracy of 80-81% 6
The American Gastroenterological Association suggests that serology should not be used for routine diagnosis of H. pylori infection, with an overall accuracy averaging only 78% (range 68-82%) 7

The National Institute of Diabetes and Digestive and Kidney Diseases advises against using serology to confirm eradication of H. pylori infection, as antibodies persist for months to years after eradication 7
Validated IgG serology may be considered when a patient has recently used proton pump inhibitors or antibiotics and medication washout is not possible, as recommended by the European Helicobacter Study Group 6

For patients younger than 50 years who have no alarm features, a “test‑and‑treat” approach is advised: perform a non‑invasive diagnostic test (either a 13C‑urea breath test or a laboratory‑validated monoclonal stool antigen assay) and, if positive, initiate eradication therapy without proceeding to endoscopy. This strategy streamlines care and avoids unnecessary invasive procedures. 8, 9